- Contact ASEHA
- ASEHA Leaflet Series
- Air Quality and Health Effects
- Allergy and Allergy Like Health Conditions
- Multiple Chemical Sensitivity
- Disability and Medical Issues For MCS and Allergy
- Children's Health Issues
- Web Links
- Search ASEHA
- ASEHA Press Releases
- ASEHA Submissions
MCS Government Review
Australian Government Review of MCS 2006 -
Australian Government Review of MCS 2006/2007
2010 Review Update
The Draft Report prepared by the National Industrial Chemicals Notification and Assessment Scheme (NICNAS) and the Office of Chemical Safety and Environmental Health (OCSEH)
In April 2006 The Office of Chemical Safety for the Australian Government, appointed Drs Bollen and Whicker of BMP Healthcare Consulting (BMP) as consultants to undertake a clinical review of the available research and education strategies which support the current diagnosis and approaches to management of Multiple Chemical Sensitivity (MCS).
Following on from the BMP report NICNAS and the OCS have asked the NICNAS Community Engagement Forum (CEF)to develop an MCS Community Engagement stratergy to guide any consultations with Professionals and the community. The MCS Review was discussed at the NICNAS Community Engagement Forum (CEF) held on the 15 May 2007. The the CEF discussed appropriate mechanism(s) for communicating the findings of the report to the broader community. It was noted that there are two main groups for consultation - sufferers and professional groups - and communications will need ot be tailored to the needs of each. The CEF will re-consider this matter once they have the draft report, expected towards the end of June 2007. A reference to MCS can be found at the NICNAS CEF link CEF July 2007 Newsletter
As a potential stakeholder ASEHA was asked a series of pre-defined questions. To answer these questions a document was prepared in June 2006 by ASEHA representatives and MCS sufferers, Dorothy Bowes and Dr Sharyn Martin. This document provides an overview of the current state of knowledge of Multiple Chemical Sensitivity drawing on credible scientific and medical references. Incorporated are real problems and actual experiences that ASEHA has encountered through its advocacy work and communications with ASEHA members and the public. Use this link to view the document - Multiple Chemical Sensitivity: 2006 Review of the Evidence or download the pdf file MCS Clinical Review - MCS A review of the Evidence 2006
A review of Multiple Chemical Sensitivity is currently being undertaken by Australia's principal chemical regulatory authorities the National Industrial Chemicals Notification and Assessment Scheme (NICNAS) and the Office of Chemical Safety (OCS). As part of the NICNAS/OCS community consultation process, an initial draft report, dated May 2008 and titled: “A Scientific Review of MCS: Identifying Key Research Needs.” was circulated to community interest groups. Subsequently a community consultation meeting to discuss the draft report was held in Canberra on 30 October 2008 with representatives from NICNAS, OCS, and community interest groups in attendance.
A working draft of the report has been released for public comment and is available on the NICNAS and OCS websites of (www.nicnas.gov.au) (www.ocs.gov.au). The links to the report are http://www.nicnas.gov.au/Current_Issues/MCS.asp and http://www.health.gov.au/internet/main/publishing.nsf/Content/ocs-mcs.htm. NICNAS and OCS consider this report a high priority area. Submissions to NICNAS closed 15th of January 2009.
ASEHA felt that the report shows undue bias towards a psychiatric/psychogenic aetiology and has failed to give due consideration to the full range of possible physiological mechanisms, for example genetic markers in MCS. In its present form we believe the report will do more harm than good. Should MCS become known by regulatory authorities as a psychogenic illness this will stigmatise MCS which in turn may affect your ability to get safe and appropriate medical care and disability access essential services. Those with Chronic Fatigue Syndrome were put in a similar position in 2002 when the RACP developed their clinical guidelines.
ASEHA and many other groups responded to this review, these can be viewed on the NICNAS website http://www.nicnas.gov.au/Current_Issues/MCS.asp
ASEHA's response to the draft review is in two document
Response to MCS pre-consultation draft ASEHA response to mcs pre consultation draft.pdf and
An addendum ASEHA Addendum to the MCS Review09.pdf that provide additional scientific and medical information to address issues following the community consulation meeting. These issues are listed below
1.Evidence of harm from low levels of chemicals, and complex mixtures of chemicals.
Last Updated (Tuesday, 02 March 2010 00:32)